Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC2389415

Cellular Dynamics International iCELL Cardiomyocytes, 5 x 10^6 viable cells/vial, cryopreserved, >95% cardiomyocytes purity, assay-ready 4 days post-thaw

Catalog No. NC2389415 Shop All Cellular Dynamics International Products
Encompass

FUJIFILM Irvine Scientific iCell Cardiomyocytes are high-purity, human induced pluripotent stem cell (iPSC)-derived cardiomyocytes tailored for cardiac research applications. These advanced cells serve as a reliable in vitro model for drug discovery, cardiac safety assessments, and disease modeling, exhibiting characteristics that mimic native human cardiomyocytes, such as synchronous beating and electrophysiological responsiveness. They are provided in a cryopreserved format, enabling rapid utilization in experiments.

  • Terminally differentiated from human iPSCs
  • Purity exceeding 95% cardiomyocytes (cTNT+)
  • 5 x 10^6 viable cells per vial
  • Assay-ready in as little as 4 days post-thaw
  • Minimal handling requirements
  • Supported media for plating and maintenance
  • Spontaneous contractile activity and stable gene expression profile
  • Suitable for cardiac safety assessment, drug discovery, and research

Catalog No. NC2389415 Supplier Cellular Dynamics International Supplier No. C1058
May include imposed supplier surcharges.
Add to Cart
Add to Cart

FUJIFILM Irvine Scientific iCell Cardiomyocytes are high-purity, human induced pluripotent stem cell (iPSC)-derived cardiomyocytes tailored for cardiac research applications. These advanced cells serve as a reliable in vitro model for drug discovery, cardiac safety assessments, and disease modeling, exhibiting characteristics that mimic native human cardiomyocytes, such as synchronous beating and electrophysiological responsiveness. They are provided in a cryopreserved format, enabling rapid utilization in experiments.

  • Terminally differentiated from human iPSCs
  • Purity exceeding 95% cardiomyocytes (cTNT+)
  • 5 x 10^6 viable cells per vial
  • Assay-ready in as little as 4 days post-thaw
  • Minimal handling requirements
  • Supported media for plating and maintenance
  • Spontaneous contractile activity and stable gene expression profile
  • Suitable for cardiac safety assessment, drug discovery, and research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.